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Abstract
Utah Valley Hospital (UVH) implemented a stereotactic radiosurgery (SRS) program as an
additional line of service. SRS as defined by the American College of Radiology is radiation
therapy delivered via stereotactic guidance with approximately 1 mm targeting accuracy to
intracranial targets in 1-5 fractions. Effectively implementing the SRS program at UVH requires
the adoption and implementation of hardware and software technologies, a review of the
clinical workflow with appropriate quality assurance tests, and the assessment of additional
technologies that will further enhance the capabilities of the program. The scope of this work is
to include a comprehensive writeup of the work that has been performed to implement the SRS
program at Utah Valley Hospital.
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Introduction
Stereotactic radiosurgery (SRS) as defined by the American College of Radiology is radiation
therapy delivered via stereotactic guidance with approximately 1 mm targeting accuracy to
intracranial targets in 1-5 fractions.1 This treatment technique was initially developed to treat
arteriovenous malformations, meningiomas, and acoustic neuromas.2 Over time the treatment
technique was further expanded to include malignant tumors, such as gliomas & brain
metastases; functional disorders, such as trigeminal neuralgia; and movement disorders, such
as essential tremors.2,3 Neurosurgeon Lars Leksell is considered the pioneer of radiosurgery
treatment where he proposed using small fields of radiation to treat structures in the brain
instead of the conventional stereotaxic treatment technique.4 The conventional technique
involves inserting a needle electrode into a targeted brain structure and performing
electrolysis.4 Leksell's proposal led to the development of the Gamma Knife, which is a
noninvasive stereotaxic radiosurgery device that uses many beams of gamma radiation to
accurately administer a high dose of radiation to a single spot.5
To this day, Gamma Knife is still considered the gold standard for SRS treatments,
however, historically; there have been a variety of longstanding criticisms regarding the use of
this device that are still prevalent. To ensure accurate delivery of the radiation, the absolute
positioning of the patient must remain fixed starting from when the patient’s planning images
are acquired up to treatment delivery. This requirement is met by affixing a frame to the
patient’s cranium which has been reported as a traumatic experience by patients, in addition to
the increased risks of bleeding and infection.6 Head frames present additional challenges such
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as requiring additional patient management from the nurse(s) & physician(s) involved, and the
possibility of frame slippage occurring which may result in a compromised treatment.6
With the advent of new technology such as 3-D image guidance, a 6 degree of freedom
(DOF) couch, & surface tracking, there has been a shift in frame-based SRS treatment
techniques to frameless. Furthermore, there has been an increase in the utilization of LINAC
based SRS treatments using either multi-leaf collimators or cones. Several vendors have
incorporated frameless techniques in conjunction with their radiation therapy devices. For
example, the Cyberknife from Accuray, the TrueBeam by Varian, and the Gamma Knife by
Elekta have all incorporated frameless techniques.5,7,8
Utah Valley Hospital (UVH) in Provo, Utah has recently (as of 2017) acquired a TrueBeam
equipped with flattening filter (FF) & flattening filter-free (FFF) beams, kV/MV image guidance,
120 leaf MLC, cones, the Encompass immobilization system,9 a 6 DOF couch, and surface
tracking. With the acquisition of the TrueBeam and supporting equipment, UVH has undertaken
the task of incorporating the SRS treatment technique into their clinical practice.
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SRS Clinical Workflow
Successfully delivering a radiotherapy plan, considering the numerous steps, numerous
personnel, and the intricacies of each step, is a feat. Also, further challenges arise in the clinical
workflow when considering that a diverse range of technologies are integrated together.
Despite these factors, UVH successfully implemented a SRS clinical workflow, as presented in
Figure 1.

Figure 1 - SRS CLINICAL WORKFLOW
UVH's mission is to help people live the healthiest lives possible.10 It was recognized that
to ensure this goal, the department needed to incorporate many properties that indicate a
workflow of high quality. Properties that were considered are the following: efficiency
throughout the entire process, consistency at each step, more than 1 individual is trained at any
3

step in the clinical workflow, and the progress at every step is tracked. Significant efforts have
been undertaken by the department to include these properties. For example, more than 1
therapist is capable of independently performing a CT simulation. An example of consistency is
the physicists rely on a checklist when reviewing a plan that is ready for treatment approval.
The benefit of having the checklist ensures that all SRS plans are subject to the same vetting
process. An example of efficiency in the clinical workflow is the use of carepaths. Carepaths
allow the department to track the status of the SRS treatment plan, and it notifies the
appropriate individual(s) when their task or contribution is needed.
The workflow begins with the patient meeting with the physician for a consultation.
During the consultation, the physician may review items such as the medical history, the
current medical condition of the patient, prior imaging scans, the diagnosis, and other health
related items. If the patient is determined to be a candidate for radiation therapy, the physician
will discuss treatment options and what to expect during their course of treatment. Following
the consultation, the patient is scheduled for a computed tomography (CT) simulation and to
undergo a magnetic resonance imaging (MRI) exam.

Computed Tomography Simulation & Magnetic Resonance Imaging
To define targets and organs at risk (OARs) for a SRS radiotherapy treatment plan, CT and MR
DICOM image sets are needed. Following the CT simulation, CT images are acquired of the
patient. This process begins with the therapist working with the patient to create
immobilization devices to limit the patient’s movement during treatment and to provide
support devices that ensure a comfortable, reproducible setup. First, the patient is asked to lay
in a head first supine position on the Encompass system (See Figure 2) which is placed on the CT
4

table. Also, a head-cup rest, adjustable pegs for the hands, and a knee sponge are included to
provide structural support.

Figure 2 - ENCOMPASS SRS IMMOBILIZATION SYSTEM

Next, a Qfix thermoplastic mask system is created.9 The mask, as seen in Figure 3, consists of
two components: an anterior and posterior piece.

Figure 3 - QFIX FIBREPLAST MASK
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To create the mask, it is first heated in a water bath, and then it is molded to the surface of the
patient’s cranium. The mask is held in place until it cools and stiffens. The back piece is created
first as it integrates into the Encompass immobilization system. This process is repeated for the
anterior portion of the mask. The anterior portion of the mask also includes adjustable shims in
0.5 mm increments that can be loosened or tightened to account for slight changes in the
patient’s anatomy throughout their course of treatment. Additionally, the anterior mask
component includes an open orbital region, which allows for surface tracking during treatment
using the VisionRT system.11 Once the mask is created, a CT scan of the patient’s cranium is
acquired. The SRS scan protocol consists of 0.8 mm thick slices with a scanning length from the
most superior part of the Encompass structure to the inferior portion of the patient's cranium.
This scan length ensures all the necessary anatomical and support structures are accounted for
in the planning CT. Additionally, a high mAs of around 1300 per slice is used to improve the
image quality, or more specifically, to reduce the mottle in the image. This increase in mAs
results in an increase in the contrast to noise ratio.
Ideally, on the same day, a 3T MR is also acquired of the cephalic region. Scans from the
MR provide superior tissue resolution when compared to the CT. Once both image sets are
acquired, the medical physicist will perform an image registration which superimposes the
anatomical information from the MR onto the CT. First the physicist will take advantage of the
auto-matching feature to perform a registration between the two images and there may be a
few fine, manual adjustments. This image registration allows the Radiation Oncologist and/or
the Neurosurgeon to accurately contour high-resolution target(s) and OAR(s) onto the CT. Once
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completed, the case is sent over to the dosimetrists to create a radiotherapy treatment plan
using the CT images.

SRS Treatment Planning
In creating a radiotherapy plan, dosimetrists usually use a 6 MV flattening filter-free (6X FFF)
beam due to its sufficient depth into the cranium, its high dose rate (1400 MU/min), its sharp
dose fall-off, and low neutron production. To spare the normal tissue and to improve
conformity the dosimetrists will include at least 500˚ of rotation in the gantry motion. This
criterion is met by adding in 5 100˚ arcs or 1 360˚ arc with 3 oblique arcs. Avoidance sectors
may be added to the arcs to avoid having radiation enter through the critical organs (e.g. the
eyes). Adding in the avoidance sectors will result in less degrees of rotation. However, in such
circumstances, additional degrees of rotation are added onto other arcs. The couch kicks are
added in conjunction with the arcs. For example, if the dosimetrist adds in 1 360˚ coplanar arc
with a couch kick of 0˚. Next, two noncoplanar partial arcs are added, one with a couch kick 3040˚ clockwise, and the other counterclockwise. Finally, the 4th arc is added with the couch
rotated normal to the 0˚ position with a vertex arc. The collimator for all arcs is rotated (e.g.
30˚) to reduce dose overlap from the multi-leaf collimator (MLC) interleaf leakage and tongue
and groove effects. Upon adding the arcs, the dosimetrist will use an optimizer technique, as
presented by the Radiation Oncology Department at the University of Alabama.12 This
technique involves radially expanding from the planning target volume (PTV) by a known
distance and creating a spherical contour. Three spherical contours are created and assigned a
priority to limit the dose in that structure which results in lower doses delivered to the normal
tissue. Figure 4 showcases an example of the spherical contours generated.
7

Figure 4 - SRS CONTROL SPHERES

The radial distances used in generating each control sphere are listed in Table 1.

Table 1 – RADIAL DISTANCES USED TO GENERATE CONTROL TARGETS
Control
Inner
Middle
Outer

Inner Surface
Edge of PTV_Total
5 mm from PTV_Total
10 mm from PTV_Total

Outer Surface
5 mm from PTV_Total
10 mm from PTV_Total
30 mm from PTV_Total

The dose constraints and their corresponding priorities for each control sphere are listed in
Table 2.

Table 2 - OPTIMIZATION SETTINGS
Control
Inner Control
Middle Control
Outer Control

Dose constraint
Dmax < 98% of prescription dose
Dmax < 50% of prescription dose
Dmax < 40% of prescription dose
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Priority
150
100
80

Although the guide for planning above represents the general SRS case, there can be
variations in the planning process that will lead to deviations. The constraints and priorities may
change depending on the treatment site, the treatment volume, the OARs, the OARS spatial
location relative to the target(s), and other factors. Once a clinically acceptable plan is
generated, the plan is evaluated for its PTV coverage and OAR sparring.
One OAR constraint that is included in every SRS plan, is the volume of brain receiving
12 Gy or more (

). Numerous publications,13–15 have reported on the complications

following SRS treatment and one of those complications is radionecrosis. Symptoms associated
with radionecrosis can include seizure, motor deficiency, cognitive deficits, and speech
deficits.14

is a dosimetric quality parameter that has been correlated to radionecrosis.

Therefore, two planning objectives are added to the plan to track this parameter. The first
planning objective reports on the

present in the brain while the 2nd objective is a

conservative estimate which only includes the normal brain tissue (i.e. Brain sub PTV).
In addition to the

constraint, there are three parameters that are tracked that

provide feedback on the quality of the plan. The three metrics are conformity index (CI),
Paddick gradient index (GI), and homogeneity index (HI). The goal is for the CI to be equal to 1
which indicates the volume of the prescription isodose line is equal to the volume of the PTV. A
value less than 1 indicates the PTV may be insufficiently covered by the prescribed dose. While
a value greater than 1 indicates that the prescription isodose line volume is covering more than
just the PTV but also nearby normal tissue. A visual scroll through is performed by the reviewing
staff to ensure that the 100% isodose line volume is superimposed on the PTV volume. The
equation used to calculate CI is presented by Equation 1.
9

=

[1]

– Volume of the prescription isodose line in ccs
– Volume of the PTV in ccs

A high dose fall-off outside the PTV or in the normal tissue is highly sought after. The GI
is calculated to characterize this dose fall-off. The GI is calculated by taking the ratio of the
volume of the 50% isodose line to the volume of the 100% isodose line. The equation used to
calculate this metric is represented by Equation 2.
=
%,
%,

%,

[2]

%,

– Volume of the 50% prescription isodose line in ccs
– Volume of the 100% prescription isodose line in ccs

Homogeneity index, the final metric, is an additional metric to assess the dose fall-off and the
magnitude of the hot spot relative to the prescription dose. Equation 3 is used to calculate HI.
=

!"#
!

[3]

$%& – The maximum dose
$ – The dose prescription for 1 fraction

With an ablative dose delivered, the hotspot inside of the PTV is of less concern. Instead a
greater hotspot can be advantageous as the dose fall-off outside the target can be greater than
a dose profile that is relatively flat. This concept is illustrated in Figure 5.
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Figure 5 - HOTSPOT RELATION TO DOSE FALL-OFF

In Figure 5, the orange line represents a plan with a greater dose in the center of the target and
is followed by a sharp fall-off. As compared to the blue line which has a relatively low dose in
the center and has less of a dose fall-off. If the length of the PTV is the same distance as the
intersection point between the two curves, as seen in Figure 5, and both curves encompass the
target with 100% of the prescribed dose, the orange line is most beneficial in providing an
ablative dose to the target while sparring the surrounding healthy tissue.
After creating a SRS plan, the dosimetrist will review the plan with the Radiation
Oncologist for any final changes before having the plan approved. Once the plan is approved,
the physics team will generate patient specific QA plans. The plans generated include: a portal
dosimetry plan, a film measurement plan, and an ion chamber measurement plan.

Ion Chamber Measurement
Prior to patient treatment, the treatment delivery is simulated to verify the absolute dose to a
point (small volume) and the corresponding MU. This is performed by using Standard Imaging’s
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stereotactic dose verification phantom with a cavity drilled for placement of the Exradin A26
ion chamber (IC).16 A verification plan is generated where the beam parameters (MLC
trajectories, energy, dose rate, etc.) from the clinical plan are computed on a CT dataset that
includes the Standard Imaging phantom with the ion chamber. Upon calculating the dose in the
phantom, the dose profile is evaluated on the axial scan in the anterior to posterior direction
and in the left to right (lateral) directions. Ideally, the dose profile should be flat in all measured
directions to avoid significant volume averaging effects. If the active volume is in a region of a
high dose gradient, the isocenter of the treatment fields is shifted to a flatter dose region.
Lastly, the plan is approved (planning approved) in Eclipse and scheduled as a QA plan which is
to be delivered on the TrueBeam.
To prepare for the IC measurement, the phantom is placed on the treatment couch and
set to isocenter. Then it is centered using the light field cross hairs with a set field size of 10x10
cm and lasers. The A26 is placed in the cavity and connected to the electrometer by a triaxial
cable. Figure 6 displays the phantom setup with the chamber in place.
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Figure 6 - STEREOTACTIC DOSE VERIFICATION PHANTOM WITH A26 CHAMBER

Next a reference MU of 100 is delivered to the phantom setup. This reference dose
measurement is recorded in units of nC or mR, depending upon the electrometer used. Then
the patient specific plan is loaded at the treatment console. Before beam delivery, a cone-beam
CT scan is acquired and registered with the planning CT dataset to minimize setup errors. Then
each arc is delivered to the phantom and the reading from the electrometer is recorded. The
reference dose measurement and the reading(s) acquired from the patient specific plan can be
used to calculate the dose measured in the active volume of the detector. Equation 4
represents the relation between the reference dose measurement to the plan dose
measurement.
$ = )*+

,-

∗

/0#1
234

5

67

100*:

)*+ ,- – The tissue maximum ratio for a 10x10 ;< field, for a known energy, depth 5 cm, set to 100 cm SAD
+=>&? – The reading measured by the electrometer from running the patient specific planned field
+ ,- – The reading measured by the electrometer from a 10x10;< , 100 MU, depth of 5 cm field
$ – The calculated dose reading from the measured patient specific planned field
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[4]

The TMR and reference reading, for the same setup, allows additional arc
measurements to be calculated in units of cGy. The dose value ($ ) is compared to Eclipse's
dose predicted value. UVH's ideal and acceptable agreement for each arc measurement and the
cumulative sum is within 3% and 5%, respectively.
Performing the IC measurement presents a few advantages over other QA techniques.
This technique allows for the determination of an absolute dose point comparison to the
treatment planning system (TPS) whereas other QA techniques may only make relative dose
comparisons. Additionally, temperature and pressure correction factors aren't required
because the correction factor would cancel out due to +=>&? and +

,-

both needing the

correction. Other advantages of this technique are the integration of the CT images and imaging
aspect into the QA process. Also, this QA technique involves a relatively simple calculation only
requiring the use of a TMR for a standard field size and depth. Therefore, it limits the
introduction of additional uncertainties. For example, if +

,-

was measured off-axis and for a

different field size then additional correction factors would have to be introduced and thus
increasing the total uncertainty. There are a few disadvantages to this technique, in that the
physicist needs a to spend time setting up and aligning the phantom. Additionally, the QA
process is quite involved which can lead to greater possibilities of operator error. For example,
when loading the QA plan at the treatment console there are options to set the couch rotation
option to 0° throughout the beam delivery process. If the operator selects this option, it will
lead to erroneous results as the QA plan includes couch rotation.
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Portal Dosimetry
Portal Dosimetry,17 supplied by Varian, is a software platform used to verify intensity
modulated plans on the MV imaging panel. The panel, also known as the electronic portal
imaging detector (EPID), is an amorphous silicon flat panel (aS1200) that extends from the base
of the gantry to isocenter. The panel includes an active imaging area of 43.0 x 43.0 cm with a
pixel matrix of 1280 x 1280 and a spatial resolution of 0.035 cm (76 dpi).18 This resolution is
sufficient in making small field dose profile comparisons. For comparison, the UVH film analysis
is performed at 96 dpi and this dpi can be greatly increased (e.g. 12,800); although there is
diminishing returns as the dose gradient is already well characterized.
The radiation plan is delivered to the panel and the signal generated is recorded. During
delivery, the couch remains at 0° and the gantry rotates with MLC/jaw motion, dose rate,
energy, etc., as it would for the patient treatment delivery. This measurement method falls
under the category of a perpendicular field-by-field analysis as classified by TG-218.19 The
recorded information (fluence) is represented in a matrix of pixels calibrated in units of
calibration unit (CU). This matrix of CUs can be compared to a predicted dose distribution
created in the software. The software component consists of a 2-D convolution portal dose
image prediction (PDIP) algorithm that predicts the fluence delivered to the EPID. The
measured and predicted fluences are compared in the Portal Dosimetry workspace using the
gamma analysis test. This graphical user interface comparing the measured and predicted
fluences is displayed in Figure 7.
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Figure 7 - PORTAL DOSIMETRY WORKSPACE: GRAPHICAL USER INTERFACE

The gamma analysis criteria consisted of a dose difference and distance-to-agreement of 1%
and 1mm, respectively. This gamma analysis showcases that 99.9% of the points compared
have a gamma value less than 1. It should be noted that for the analysis of each arc, it is split
into multiple subarcs. The arcs are split to avoid masking potential dose delivery errors in a
composite dose analysis.
The advantages of performing the PD QA is it is integrated into the software of the
department's TPS and LINAC. For example, the PD plan can quickly be computed in the Eclipse
workspace within a few mintutes. Then if the therapists have a ~5-10 minute open timeslot,
they can perform the QA as it only requires the MV imaging panel to extend and doesn't
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require the setup of a phantom. The disadvantage to using this QA technique is it isn't exactly
independent from the LINAC system and it doesn't include the couch rotations in the QA plan.
Setting up a Portal Dosimetry QA program requires commissioning the PDIP algorithm
and calibrating the MV panel. The following is required to calibrate the hardware: a dark field
calibration, a flood field calibration, and an imager dosimetry calibration.17 The dark field
calibration consists of measuring the response of each detector without the beam turned on
and setting this value to 0. Then a flood field calibration is acquired where the gain of each pixel
is adjusted to produce a uniform image intensity. These two calibrations must be done for each
energy and dose rate combination. Afterwards, a dosimetric calibration is performed consisting
of a beam profile correction and a dose normalization. The beam profile correction is applied by
introducing a diagonal profile that reintroduces the non-flatness of the beam. For the dose
normalization, a CU is assigned for a 100 MU 10x10 cm field. Lastly, configuration of the PDIP
algorithm requires intensity profiles, fluences, absolute calibration parameters, and output
factors.17

Film Calibration
In addition to portal dosimetry, film is also able to verify the accuracy of the relative dose plane
with the added benefit of being an end to end (E2E) test. Film QA is categorized as an E2E test
as it includes processes from start to finish (e.g. CT simulation to plan delivery). Film has
additional advantages over other available QA tools in clinic which includes the films near tissue
equivalence, its self-developing property, the affordable pricing, the range of dose response,
and most importantly, its micrometer resolution. The delivery of the film in the phantom allows
for a true composite method (dose measurement method).19 All beam delivery and machine
17

parameters are kept the same as the original patient plan when irradiating the phantom except
for the total MU due to the limited dose range of the film. Therefore, the total MU delivered to
the film is scaled down.
The film used in performing the pretreatment quality assurance is Gafchromic RTQA2
film.20 It is advertised for the use of LINAC QA (e.g. light/radiation field coincidence, starshots,
etc.) and has been adopted into the clinic due to its ample abundance. The Gafchromic film
consists of 4 layers, first a yellow polyester, a pressure sensitive adhesive, an active layer, and a
white polyester. The active layer displays a significant change in optical density (OD) following
irradiation, which can be correlated to a known dose.
To compare a measured axial plane of dose to the TPS, a sensiometric curve is required
to convert OD to dose. This curve is generated using the fragment calibration method which
involves irradiating film pieces with a known dose varying from 0 to 400 cGy. This dose range
was selected to operate in the region to be more sensitive to the change in OD per change in
dose. Following irradiation, the film pieces are scanned, and the OD is measured using
ImageJ.21 Then a 4th order polynomial trendline is fitted to the measured OD to establish the
correlation to dose. The sensiometric curve generated from the fragment calibration method is
shown in Figure 8.
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Figure 8 - SENSIOMETRIC CURVE

An axial dose plane from the patient plan is measured on film by creating a verification
plan in Eclipse that takes the field parameters and recalculates the dose onto stereotactic dose
verification phantom with a film slab instead of the ion chamber slab. Figure 9 displays the film
being positioned onto the blue slab (a piece of the stereotactic dose verification phantom) and
then with the top plate screwed into place.
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Figure 9 - LOADING THE FILM INTO THE STEREOTACTIC DOSE VERIFICATION PHANTOM
This phantom, with the embedded film, is set up in the treatment room and a CBCT scan is
taken to further align the phantom to the expected treatment position. Once in position, the
phantom is irradiated using the same treatment parameters in the clinical plan except with the
MU scaled to the dose range of the film. Afterwards, a square film (~6.35 cm x 6.35 cm) is
placed on a 5 cm thick solid water block. The film is aligned to the light field crosshair and an
additional 5 cm solid water block is placed on top. The SSD is then set to 95 cm which places the
film at isocenter. This film fragment is irradiated to a known dose, and it used to scale the
sensiometric curve when calibrating the axial plane of dose film.
The three pieces of film scanned on the Epson 10000 XL scanner include: the axial dose
plane, film fragment(s), and a background film. Since, multiple films are to be scanned, they are
centered on the scanner and placed in a vertical fashion where the aggregate of films form a
straight line that is parallel to the scan direction.22 As previously reported,23–25 lateral scan
effects (LSE) can be created due to the scan field being ununiform, which can lead to significant
discrepancies between the expected OD of the film and the measured OD. This effect was
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investigated by taking two scans of the same irradiated film at the center and at the edge of the
scanner. It was found the LSE is negligible for all films scanned at the center.
The film fragment irradiated after the axial dose plane film is loaded into ImageJ. The
OD from the film fragment is measured and compared to the expected OD from the
sensiometric curve of the same dose. The ratio of these two values is taken and used to scale
the entire sensiometric curve, which is then used to calibrate the film with the axial dose plane
from OD to cGy. Once the dose plane film is scanned in, it is also loaded into ImageJ. The film is
cropped and split into the three-color channels (RGB) where the red channel is selected and
edited for the remainder of the film analysis. The red film channel is shown to have a greater
change in OD per unit of dose than the other two channels.22 This effect is desirable as the film
displays the greatest sensitivity to changes in dose. This effect is preferable when compared to
the extremes. The first extreme is that the film is highly insensitive to the delivered dose, thus
resulting in the noise drowning out the sensitivity of the delivered dose. Additionally, the
scanner may be limited by its color bit depth where it would be unable to detect a slight change
in the OD. The other extreme would be that the film is highly sensitive to ionizing radiation
where other ambient radiation can add additional noise to the film. The dose plane films matrix
of OD is then calibrated (units from OD to cGy) using the newly created sensiometric curve.
Next, a 3D median smoothing filter with a radius of 3 pixels is applied to smooth out any
existing film defects and any scanner and scanner bed artifacts that may be the result of
imperfections in the glass or dust particulate.
Then, the matrix of dose from the film QA is exported and it is formatted before it can
be imported into Portal Dosimetry (PD). Additionally, the axial dose plane corresponding to the
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center of the film from the verification plane (from the QA plan) is also exported from ImageJ
and formatted before importing into PD. PD was originally designed with the intent of
comparing the measured dose from the EPID to the PDIP algorithm. However, in its simplest
form, PD is just comparing two matrices of data via a gamma analysis. Therefore, the film is
formatted in a manner that allows for the PD software to read the file information and to allow
comparisons of the film to an axial plane of dose. A drawing exchange format (.dxf) file is
required to successfully import the file. There are a few items that must be specified in the
header of the file. Those items include the matrix size (image dimensions, e.g. 512 x 512) and
the resolution of the image. Extra information that isn’t required to import the file, but it is
important from an accuracy standpoint, includes the patient’s name, id, the field size, the
energy, and other miscellaneous details. The complete file header is included in Appendix A.
After the file has been appropriately formatted, it can then be imported into the PD workspace.
Finally, a gamma and visual profile analysis is performed by comparing the measured dose
distribution to the TPS calculated dose distribution. Figure 10 displays an example of this
comparison.
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Figure 10 - PORTAL DOSIMETRY: FILM COMPARISON

For this gamma analysis (in Figure 10), a distance-to-agreement and dose difference tolerances
of 1 mm and 5%, respectively are used. A normalization mode of relative was set with the
option of minimizing the difference between the two datasets. In this comparison, one of the
most important parameters, is ensuring the dose fall-off agrees. The Portal Dosimetry analysis
can also assess dose fall-off. However, the film workflow includes components that are more
representative of a SRS case. For example, this film analysis involves delivering the patient's
plan onto a CT dataset that includes the phantom and film, while the PD QA doesn't include a
CT dataset. Additionally, couch walkout uncertainties are included in this test. Lastly, the
comprehensive writeup regarding the entirety of the film QA process is included in Appendix A.
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IMSure
IMSure16 is a secondary independent calculation software that compared its calculated MU and
dose to a point against the TPS. After the planning approval step, the dosimetrist will export the
plan information and CT dataset into this software to make the comparisons. This is done for
every SRS case prior to treatment. This software is a 3-source model developed at Stanford
University that models scatter from the main photon source, the scatter from the flattening
filter, and the scatter created by the main collimators. Once the plan has been planning
approved, the QA has been performed, and the IMSure check has been calculated, the case is
sent over to the physicist for review.

Physicist Plan and Contour Review
Prior to treatment delivery, the physicist will perform an initial chart check of the patient's plan.
This check is performed to, "ensure compliance with the prescription, no clinically significant
deviations are present, and that all information necessary for the therapists to deliver the
treatment has been provided".26 When OAR contours are completed, the physicist will review
those structures. Items that are reviewed include: if density overrides were used (if applicable),
the use of high-resolution segments, verifying the body contour, if the user origin is set
correctly, and the contour accuracy. Checking the contours ensures the plan is most
representative of the patient anatomy, and to prevent undesirable consequences. For example,
if there is discontinuity between the brain stem axial slices, the fluence optimizer may try to put
some amount of dose through that axial slice to aid in covering the PTV. After contour review,
the physicist will perform an additional review but of the treatment plan once it has been
approved by the physician. During this check, the physicist will perform a comprehensive
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evaluation of the plan and available documentation. The physicist will review the physician's
prescription and if the plan follows it. There is review of the documentation such as diagnostic
scans/reports, pathology findings, previous radiation treatment (if applicable), and if the
patient has consented to the treatment. Next the plan quality and pretreatment QA is
evaluated. The physicist will review the PTV coverage, OAR sparring, the SRS plan metrics (e.g.
CI), isodose lines, if the appropriate imaging is added, and reasonable MUs for the dose
prescribed.
Lastly, the physicist will review the pre-treatment QA tests and the 2nd independent
check to determine if there are any items that require further investigation prior to treatment.
For example, in the film analysis, the relative dose fall-off measured from the film is compared
to the TPS dose fall-off via gamma analysis. If for example, there was a considerable
discrepancy in the two dose fall-offs, this would serve as an alert to the physicist to investigate
this finding. One cause of this discrepancy, for example, might be due to a MLC positioning
error. Once the plan is deemed acceptable and all potential items of concern have been
addressed, the physicist will approve the treatment plan.

Treatment Procedures
Once the physicist has reviewed the patient treatment plan along with the results of the QA
and if the plan is deemed clinically acceptable, the plan is ready for treatment delivery. On
treatment day, the Encompass SRS Immobilization System is placed onto the 6 DOF couch using
the lock bars. Then the patient is asked to lay on the system in a headfirst supine position
mimicking the setup during the CT simulation. The ancillary devices used during the CT
simulation are also included, such as a plastic headrest, toeband, and/or a knee cushion. The
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QFix Encompass mask, created during CT simulation, is placed onto the patient’s head with a
shim setting of 2 (the default setting). If the mask is too tight or too loose, the shims are
adjusted until a very snug but tolerable fit is achieved. The therapists in the room will make the
appropriate marked isocenter shifts in the vertical, longitudinal, and lateral directions to the
planned isocenter. Additionally, the therapists will simultaneously interface with the VisionRT
system to assess if any residual shifts remain and if there are any rotational shifts that need to
be addressed. The VisionRT system is continuously left on to achieve a steady thermal state
which results in improved sub-millimeter stability while monitoring treatment delivery.
After the patient has been setup on the couch and VisionRT agrees with the spatial
location of the patient, the therapists will exit the vault to perform imaging. At this point, the
physicist is called into the console area to oversee the imaging. First, a CBCT scan is acquired to
perform an image registration between the planning CT and the current patient setup. An automatching tool in the image registration software is used to easily address any remaining
translational and rotational misalignments. After the registration is reviewed by the therapists
and the physicist, the shifts are made and a 2nd CBCT scan is taken with the physician present.
An advantage to taking a 2nd CBCT other than confirming the shifts, is to also verify the
clearance between the gantry and the patient and support structures while the couch is at 0°.
At the same time, a reference surface is captured on the VisionRT system to record the current
spatial location of the patient and to monitor for any deviations from the CBCT based alignment
throughout the course of the treatment. The physician and physicist will jointly review the
overlaid CBCT images to verify the alignment of the patient. If the images agree, an AP MV
image is taken using the EPID panel to confirm alignment of the skull as a final, independent
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verification before delivering the beam. The use of the MV panel allows for verification of the
CBCT imaging alignment system, thus confirming the patient is in the correct setup position.
The AP MV image is most sensitive to misalignments in the lateral and superior/inferior
directions. Vertical misalignments may manifest as a magnification error between the two
image comparisons. It could be argued that a lateral (orthogonal to the AP image) MV image
would highlight possible vertical alignment discrepancies. However, with the verification of the
spatial alignment of the patient with the MV image and the initial feedback from VisionRT, it is
deemed that the lateral MV image would provide little benefit. Once these images are
determined to also match, the treatment delivery begins. Throughout the course of treatment,
the VisionRT shift readouts are closely monitored. In the event there was a sustained shift
greater than 1mm, the beam is immediately turned off, and the patient is reimaged with a CBCT
scan at a couch angle of 0° to verify the accuracy of the patient's spatial alignment. Additionally,
to expedite the time of treatment, the couch and gantry angles are ordered in a sequence that
reduces the total rotational time. For example, if there are 4 couch angles, 0°, 45°, 90°, and
315°, the first couch angle will be 0°, since it is easiest to acquire a CBCT scan. The remaining
couch angles will then occur in the following order, a 45°, 90°, and 315°.
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Commissioning
The Acuros External Beam Algorithm27 (Acuros XB 15.6.05) is used in calculating dose
distributions for stereotactic cases. The algorithm deterministically solves the linear Boltzman
transport equation. This algorithm is known for its quick, accurate dose calculation, especially
with GPU acceleration. Uncertainties in the XB algorithm arise from the discretization of
solution variables in space, angle and energy.27 Additional uncertainties exist in how the
algorithm handles charged particle coulombic interactions. An overview of the calculation
steps, as provided by Varian,27 is included below.
1. Creating a physical map material
2. Transporting the components of the photon beam source model (primary and
secondary photon source, and electron contamination source) into the patient
3. Transporting the scattered photon fluence in the patient
4. Transporting the electron fluence in the patient
5. Calculating the desired dose mode (dose to medium or dose to water)
As seen in the first calculation step, Acuros requires the mass density and material for each
voxel which is supplied by Eclipse through a conversion of HU values.
Before any radiation transport in the patient medium, the radiation from the head of
the linear accelerator must be characterized. As outlined in the Eclipse Photon and Electron
algorithms reference guide, 27 there exists an accurate parameterized model of the radiation
output from the linear accelerator. The parameters of the model are modified by parameters
inputted by the user to construct a customized phase-space specific to the treatment machine.
For each LINAC energy, the phase space file defines the fluence and energy spectrum.
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To commission this algorithm there are a variety of measurements that need to be
inputted into the Beam Data workspace in Eclipse. The beam model at UVH was configured
using the TrueBeam Representative Beam Data (TBRBD). Table 3 lists the required scans
needed to configure the open field.

Table 3 - SCANS REQUIRED TO CONFIGURE AN OPEN BEAM (ADAPTED FROM ALGORITHM REFERENCE
GUIDE 27 )

Measured Parameter
Depth Dose Curves

Scan Axis Depth [cm]
Central Axis

Profiles

dmax, 5, 10, 20, & 30 cm

Diagonal Profile

Output Factor

Field Size [@AB ]
FS < 10x10, 10x10
10x10
Intermediate Field
Sizes.
Largest Field Size

dmax, 5, 10, 20, 30 cm

FS < 10x10
10x10
Intermediate Field Sizes
Largest Field Size
Largest Field Size

5 cm depth ≤ 15 MV

See Table 4.

10 cm depth for > 15 MV
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The list of field sizes for the output factors is listed in
Table 4.

Table 4 - OUTPUT FACTORS REQUIRED TO COMMISSION ACUROS (ADAPTED FROM ALGORITHM REFERENCE
GUIDE 27 )

Field Size
[cm/cm]
3
5
7
10
15
20
30
40

3
3x3
5x3
7x3
10x3
15x3
20x3
30x3
40x3

5
3x5
5x5
7x5
10x5
15x5
20x5
30x5
40x5

7
3x7
5x7
7x7
10x7
15x7
20x7
30x7
40x7

10
3x10
5x10
7x10
10x10
15x10
20x10
30x10
40x10

15
3x15
5x15
7x15
10x15
15x15
20x15
30x15
40x15

20
3x20
5x20
7x20
10x20
15x20
20x20
30x20
40x20

30
3x30
5x30
7x30
10x30
15x30
20x30
30x30
40x30

40
3x40
5x40
7x40
10x40
15x40
20x40
30x40
40x40

The beam data listed in Table 3 and
TABLE 4 is compared to the TBRBD via gamma analysis. Once the data is in good agreement, the
TBRBD is imported into the treatment planning system and used to configure the photon beam
source model.
Beam modifying information is also inputted into the TPS which includes but is not
limited to the jaw transmission factor, the dosimetric leaf gap, & the MLC transmission factor.
Once all this data has been imported, the beam model is further configured by optimizing the
parameters, listed in Table 5, to match the TPS’s calculated distribution with the measured
distribution.
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Table 5 - MACHINE PARAMETERS TO BE OPTIMIZED
Machine Parameters
Photon Energy Spectrum
Mean Radial Energy
Location off virtual second source, X & Y collimator jaws, and MLC
Relative intensity of the virtual second source, energy and size of the
second source
Material of flattening filter

This step is performed by using an objective function consisting of a total gamma error metric
and a penalty term. Similarly, to the comparison of the TBRBD to the measured data, this
gamma error metric will compare calculated data points to measured data points by
considering dose differences and distances to agreement. The penalty term is added into
account for noise, increasing mean energy, an increasing intensity profile, and unphysical
second source parameters.
Lastly, the Acuros parameters set in calculating a dose distribution are displayed in
Figure 11.

Figure 11 - ACUROS XB CALCULATION SETTINGS
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A calculation resolution of 0.125 cm is selected to provide a better representation of the dose
differential across the medium, especially at inhomogeneous interfaces. Lastly, to ensure an
expedient calculation time, GPU acceleration is turned on.

32

VisionRT
SRS treatments deliver a limited number of fractions (e.g. 1-5 fractions) to their target with
tight margins to the CTV (0-2 mm) with a high dose of radiation. A potential miss of the
target(s) can lead to damaging nearby healthy tissue with the risk of irreversible effects to the
patient. Additional challenges arise when the targets are adjacent to a critical structure such as
the brainstem, which is commonly seen when treating the trigeminal nerve. These risks are
further exacerbated when treating patient with a frameless mask where there is the possibility
of movement from the patient during treatment delivery.
One method to minimize such risks is to incorporate the use of surface tracking. Utah
Valley Hospital uses surface guided technology (VisionRT) for all SRS cases. The Vision RT
system consists of a three-camera pod system that uses stereoscopic video images and a
speckle pattern projected onto the patient’s surface to continuously capture and reconstruct
maps of the patient’s surface.28 Additionally, this technology compliments the Encompass mask
system as the mask has an opening around the eyes to allow for surface monitoring of the
patient. The system’s software then makes a comparison of the reference image to the current
patient’s setup and the discrepancies between the two are reported out as translational and
rotational shifts. Therapists use this information to accurately shift the couch and the patient
into the correct treatment position and to monitor for any sub-millimeter movements that may
occur during the radiation delivery.
To ensure that the camera pods have not shifted relative to each other, daily QA is
performed before any patient treatment.11 Additionally, monthly QA for the VisionRT system is
performed to calibrate the camera pods to the treatment room isocenter. The second part of
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the monthly QA is to calibrate the cameras’ ability to track surfaces above isocenter. This
calibration procedure should be performed in approximately the same lighting as when patients
are treated to avoid erroneous feedback from the system. Lastly, periodically and following any
Vision RT camera system upgrade, a MV isocenter calibration is performed. Performing the
recommended QA tests of the VisionRT system ensures the system is able to accurately predict
the shifts needed to correctly setup the patient and serves as an independent check tool for the
therapists.
Per TG-147's recommendation,28 the effects of thermal drift on the VisionRT system was
characterized. When the cameras are actively monitoring the location of a static object, the
VisionRT system will display a spatial drift in its readout of the object's location. This
phenomenon was confirmed by setting up a Styrofoam mannequin head on the treatment
couch, capturing the current position of the head with the cameras, and monitoring its location
over time. The results for VisionRT's translational thermal drift are displayed in Figure 12.
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Figure 12 - CHARACTERIZING VISIONRT'S THERMAL DRIFT
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The results suggest that in ~10 minutes the thermal drift of the VisionRT system approaches an
asymptote. This test was performed twice. In the original setup, tape was used to hold the
mannequin head in place. Since the translational shifts are being read out in millimeters, there
was concern that over time the tension from the tape may diminish which might cause the
mannequin head to slightly shift. Therefore, this test was repeated but without the tape;
however, the 2nd iteration shows similar results to the first test.

35

Machine Specific Quality Assurance
Since SRS delivers radiation treatments with a narrow margin of 1 mm (margin may slightly vary
depending upon institution) in 1-5 fractions and with a high dose; it is imperative to
characterize and to limit the uncertainties of each step and to compare with the standards
recommended by a professional organization. Therefore, recommendations from the Medical
Physics Practice Guideline (MPPG) 9.a. document endorsed by the American Association of
Physicists in Medicine29 (AAPM) is commonly referenced to ensure a safe and well-understood
treatment delivery process. Recommendations from the AAPM regarding C-arm LINAC QA tests
are displayed in Figure 13 which includes the test and its associated tolerance.30

Figure 13 - MEDICAL PHYSICS PRACTICE GUIDELINE 9.A. FOR SRS-SBRT30
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Validation of the Beam Model
Per MPPG 9.A, an end-to-end test was performed to assess the SRS clinical workflow, to
evaluate the processes performed at each step and to evaluate the overall treatment accuracy.
Additionally, this test was completed to serve as an independent audit on the current UVH SRS
program. A head phantom embedded with TLDs, film, and fiducials was ordered from the
Imaging and Radiation Oncology Core (IROC) group.31 After receiving the phantom, a Qfix mask
was created for the phantom with the aid of the therapists. Next the phantom was scanned on
the Phillips Big Bore CT using the SRS scan protocol. The scan protocol settings are listed in
Table 6.

Table 6 - CT SCAN PROTOCOLS FOR SRS H&N PHANTOM
CT Parameters
Thickness [mm]
kV
mAs/Slice
# of Images

Value
0.8
120
1305
368

After importing the CT images into the contouring workspace, the following high-resolution
structures were added: Lt and Rt Eye, Lt and Rt TLD powder, a spherical PTV contour
(~Diameter of 1.9 cm), an external body contour (encompassing the phantom head and
Encompass system), and the Encompass support structures. Additionally, the search body tool
was used at a range of -600 HU to generate a surface structure to be used by the VisionRT
system. A dosimetrist was tasked with creating a plan to deliver 25 Gy to the target with a
maximum dose of 30 Gy. The plan was calculated using the AAA algorithm (Acuros was not
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commissioned at the time) with a resolution of 0.1 cm and heterogeneity corrections turned
on.
Per our defined pretreatment QA process, the plan was delivered and recorded on the
EPID. In Portal Dosimetry, a gamma analysis was performed for each subarc with a dose
difference and distance-to-agreement criteria of 1% and 1 mm, respectively. All comparisons
had a gamma passing rate greater than 96%.
Next, a point dose measurement was taken with the blue cube phantom. All
measurements were within 5% with one measurement coming in just under 5%. The results for
each measured arc are included in Figure 14.

Figure 14 - BLUE CUBE +A26 DOSE VERIFICATION

The disagreement in the 4th arc may be attributed to the active volume of the chamber
measuring in a semi-steep dose gradient region which results in volume averaging or can be the
result of the couch walkout being greatest at perpendicular angles to 0 degrees. Overall, the
cumulative results are in excellent agreement.
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After the physics team reviewed the plan, it was determined to be acceptable for
treatment delivery. The phantom was setup in the Encompass system by the therapists with the
guidance of VisionRT. Also, the attachable ears were placed on the outside of the mask as it’s
used by IROC as an imaging background measurement. After the VisionRT values were within
tolerance, a CBCT scan was taken to correct any residual setup errors. After comparing the
CBCT scan to the planning CT and shifting the phantom, the ears were removed, and the plan
was delivered to the phantom. Next, an output measurement of the TrueBeam was required
from IROC where the TLD was irradiated. This involved setting up a TLD block on a plastic
platform with a set SSD of 100 cm and a field size of 10x10 cm .
Following irradiation, the phantom was sent back to IROC along with isodose
distributions in the coronal and sagittal planes through the center, screenshots showing the TLD
contour, the DICOM information (CT, RD, RP, and RS files), and trajectory log files. The gamma
analysis results for the film were deemed acceptable. A 5% dose difference and 3 mm distance
to agreement were set as the tolerance values. The coronal and sagittal planes had a gamma
index of 98% and 97%, respectively. Additionally, the TLD results were deemed acceptable as
the average ratio of the measured recorded dose of the TLD as compared to UVH’s TPS
recorded value was 1.01. The full report can be found in Appendix B.

Winston Lutz Test
Another QA performed, which is also recommended in the MPPG 9.a, is the Winston Lutz test.32
This test allows for the verification of the congruency between the radiation and mechanical
isocenters. The linear accelerator has three mechanical axis of rotation that includes the gantry,
collimator, and couch. All three of these mechanical axes intersect at a point known as
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isocenter. A small spherical radiopaque ball mounted onto a thin rod is attached to the
treatment couch with various dials to adjust the position of the ball in the x, y, and z planes. The
ball is approximately aligned to isocenter using the intersection of the lasers and evaluating the
projection of the ball’s shadow relative to the light field cross hairs. Figure 15 displays the initial
setup of the ball.

Figure 15 - INITIAL WINSTON LUTZ ROD SETUP

Once the ball is visually aligned, MV images using the EPID panel are taken at gantry angles of 0
and 90 degrees. These images are used to further refine the placement of the ball to isocenter.
This test was originally designed to test the coincidence of the radiation and the mechanical
isocenter. However, with the incorporation of the imaging component, one can analyze the
imaging and treatment coordinate coincidence and test the position and repositioning of the
couch, based on the suggested shifts from the imaging system. Once the ball is aligned to
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isocenter, a MV image is acquired for various combinations of the gantry, couch, and collimator
angles. These images are saved in a DICOM format and they are imported into a software
program, such as PIPSPRO, for analysis. An example of the analysis is displayed in Figure 16
where the ball's position relative to the field size is characterized.

Figure 16 - WINSTON LUTZ ANALYSIS

Performing this test satisfies many of the recommended QA tests outlined in TG 14233
and MPPG 9a.30 These image pairs are taken using either a cone or with the MLCs. In all SRS
cases, a cone could be used to perform the Winston Lutz test and only for MLC cases the MLCs
may be used.
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Monthly Output
The constancy of the output for relevant dose rates of the accelerator for all photon and
electron energies is verified. To measure the output of the 6 MV FFF beam (the energy
commonly used in SRS cases), the gantry, collimator, and couch are set to 0 degrees. A 5 cm
thick solid water phantom followed by a 2 cm thick solid water phantom with a hole drilled for
an ion chamber is placed on the treatment couch. The 2 cm block contains inscribed black lines
with an area of 10x10 cm . The blocks are centered using the light field and the inscribed black
lines with a set SSD of 100 cm. A thermometer is placed into that cavity to measure the
temperature while a barometer is used to record the pressure. These two values are used to
correct the ion chamber readings by accounting for the change in the mass of air present in the
chamber. Next the thermometer is taken out of the cavity and a PR-06G farmer chamber is
placed in its stead, and the chamber is connected to an electrometer with a voltage of 300 V.
Once the block is setup, an additional 2 cm block is placed on top of the current setup, putting
the chamber at a depth of 3 cm with a SSD of 98 cm. The SSD is set back to 100 cm by adjusting
the vertical height of the couch. An example of this setup is displayed in Figure 17.
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Figure 17 - MONTHLY WATER PHANTOM OUTPUT SETUP

Once the setup is complete, 100 MU at a dose rate of 1400 MU/min is delivered to the
ion chamber for a field size 10x10 cm with a gantry angle of 0°. A 2nd reading is always taken
for the first measured energy (6 MV) to verify constancy of the chamber. Finally, an energy
measurement is taken by placing 25 brass plates on the central axis and an additional reading is
recorded. Figure 18 displays the readings taken through the 2019 year for output and energy
verification.
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Figure 18 - MONTHLY OUTPUT CHECK ON THE 6X FFF BEAM

The results from Figure 18 showcase the all monthly output measurements were within 1%
from baseline. Per MPPG 9.a. recommendation, the monthly output constancy is to be within
2%.

Electronic Portal Imaging Detector QA
At the time of writing this document, there is not a formal document from the AAPM
addressing Electronic Portal Imaging Dosimetry (EPID) based QA. Therefore, UVH’s EPID QA
process is presented here to illustrate steps taken by the Radiation Oncology department to
ensure proper operation of the EPID. The EPID QA tests are presented in Table 7.

Table 7 - MONTHLY EPID QA
EPID QA Checks
Graticule Accuracy for Jaws & MLC
X-ray vs. Light for Jaws & MLC
Image Quality
Dosimetric Constancy
Integrated Image Alignment Accuracy
Picket Fence Test
Tongue & Groove Leakage
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First a test is performed to evaluate the physical and digital graticule accuracy. The
physical graticule is slid into the treatment head slot and an image is recorded on the panel. In
offline review, the center from the physical graticule is compared to the digital graticule by
determining the x and y discrepancies between the two. Next an x-ray vs. light field comparison
is made by measuring the distances acquired at the time of image acquisition and the recorded
image is then measured. The contrast resolution is assessed with the Las Vegas phantom by
evaluating the number of distinguishable holes of different depth and diameter. A dosimetric
calibration check is performed by delivering 100 MU to the panel and going into the PD
workspace and analyzing the max CU recorded at the central axis and comparing this value to
baseline. An image alignment accuracy is checked by using the PD software to match the
expected dose distribution with the measured dose distribution. These values are tracked to
serve as a constancy check of panel positioning vs. the treatment beam. A MLC performance
test is conducted through the picket fence pattern where the MLCs move in unison to
programmed positions with a small amount of MU delivered at each dwell position. This test is
designed to identify any possible MLC positional or speed errors. Finally, a tongue and grove
leakage constancy check is performed by measuring the highest recorded dose in units of CU
measured with the MLCs in a closed position.

Mechanical QA
Mechanical quality assurance tests are performed on a monthly basis to ensure continuity in
the accurate radiation delivery of the LINAC. The monthly mechanical checks are listed in Table
8.
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Table 8 - MONTHLY MECHANICAL QA
Mechanical Checks:
Gantry/Collimator Angle Indicators
Collimator Walkout
Graticule vs. Crosshair
Mechanical Pointer & ODI Agreement
X, Y Jaws Close Symmetrically Around Crosshair
Field Size Check (Symmetrical & Asymmetrical)

A digital leveler is placed onto the treatment head with the gantry at 270 degrees. The
collimator is rotated until the leveler reads out the angle of interest. The collimator readout
from the LINAC is then recorded. Figure 19 displays an example of the collimator angles tested
with the corresponding measurement.

Figure 19 - COLLIMATOR ANGLE INDICATOR

Next, the gantry angle indicator is verified with the leveler by rotating the gantry to
various angles of interest using the leveler and reading out the gantry angle. The recorded
results are presented in Figure 20.
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Figure 20 - GANTRY ANGLE INDICATOR

Next, a 1 mm spaced grid paper is set on the treatment couch at 100 cm SSD. An
intersection of the vertical and horizontal grid lines is aligned to the central axis light field cross
hair. The gantry is returned to 0° and the collimator is rotated from 90° to 270° to discern any
noticeable crosshair and light field walkout. Next, the collimator is closed along the crosshair to
identify if there are any asymmetries. Figure 21 presents those recorded values.

Figure 21 - COLLIMATOR WALKOUT AND SYMMETRY OF JAWS

Next a comparison is made between the optical distance indicator as compared to the
mechanical front pointer. Both measurements should read out a distance of 100 cm. The
physical graticule is then slid onto the treatment head and its alignment is checked against the
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light field graticule. Finally, the independent jaw readouts are compared by the light field
projection onto the graph paper. This is done for all 4 jaws (X1, X2, Y1, & Y2) for various
positions and again grouping the y and x jaws. Figure 22 and Figure 23 represent the jaw
position measurements for the symmetry and asymmetry, respectively.

Figure 22 - JAW POSITION INDICATORS (SYMMETRIC)

Figure 23 - JAW POSITION INDICATORS (ASYMMETRIC)
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Computed Tomography Quality Assurance
Acquiring a CT scan allows for contouring and treatment planning. It is desirable to obtain an
accurate dataset that best represents the patient’s anatomy with accurate image quality.
Therefore, every month, the CatPhan 604 is scanned and a series of tests, as seen in Table 9,
are performed to evaluate CT images.

Table 9 - MONTHLY CT QA
Monthly CT Simulator QA: Image
Quality
Image Noise & Uniformity
HU Constancy
Low Contrast, High Resolution
In Plane Spatial Accuracy
Longitudinal Spatial Accuracy

The CT dataset that is evaluated every month is the SRS HEAD scan protocol which
consists of 0.8 mm slices. Image noise and uniformity (from Table 9) is assessed by measuring
the mean HU and standard deviation at the center of the phantom and then the HU at the
following locations: 12, 3, 6, and 9’O clock. A region of interest of 1 cm by 1 cm is used when
measuring the HU. This process is represented by Figure 24. The HU of each position is
expected to be around 0 with an expected standard deviation of 20.
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Figure 24 - IMAGE NOISE & UNIFORMITY

Next a HU constancy check is performed by evaluating the various plugs. This is
performed for the following materials: air, Teflon, Delrin, bone 20%, bone 50%, acrylic,
polystyrene, LDPE, and PMP. Figure 25 displays the plugs present in the phantom.

Figure 25 - HU CONSTANCY CHECK
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Image quality is evaluated by assessing the high and low-resolution contrast. Figure 26
represents low contrast test where the number of visible circles is counted and compared to a
baseline.

Figure 26 - OUTER LOW CONTRAST
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Figure 27 represents the high contrast test where the number of distinguishable line pairs is
counted and compared against baseline.

Figure 27 - LINE PAIR RESOLUTION

Finally, the constancy of the in-plane and the longitudinal spatial accuracy is evaluated
measuring known distances between objects in the phantom. For example, measuring the
distance between the two upper holes that gives a distance of 5 cm and measuring the diagonal
distance between two of the holes yields a distance of 7.07 cm. The in-plane and longitudinal
measurements are displayed in Figure 28 and Figure 29, respectively.
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Figure 28 - IN PLANE SPATIAL CONSTANCY

Figure 29 - LONGITUDINAL SPATIAL CONSTANCY
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Machine Performance Check
Every morning when the therapists perform the daily QA to verify items such as the output, the
positioning and repositioning of the couch based on imaging, and other tests, they also run the
machine performance check (MPC).34 MPC is a software package supplied by Varian that
performs geometry and beam checks for the LINAC and that data is displayed as a trend chart.
A complete list of the checks as performed by MPC are listed in Table 10.

Table 10 - MACHINE SPECIFICATIONS
Geometry Checks
Treatment Isocenter Size & Location
Coincidence Between Treatment Isocenter & MV
& kV Imaging Isocenters
Collimator Rotation Offset
Gantry Positioning Accuracy
Couch Position Accuracy for 6 DOF
MLC Leaf Position for Inner Leaves

Beam Checks
Beam Output
Constancy
Beam Profile
Constancy
Beam Center Shift

This tool does not replace any of the existing QA performed by the department but is an
extension of the QA program. Instead, it is complimentary to the current QA program as it
provides an immense amount of high precision data on many critical sub-systems of the LINAC,
serves as an independent check from the current QA program, and adds confidence to the
LINAC performance. An example of the graphical user interface alongside the data displayed is
shown in Figure 30.
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Figure 30 - MACHINE PERFORMANCE CHECK DATA

To give an example of MPC's utility, there was a slight but noticeable trend in the output
increasing over time. The physicist performed an absolute calibration (TG5135) to bring the
beam's output back down. However, before doing so, having the beam output measurement
from MPC allowed the physicist to compare that value to the daily and monthly output
measurements. It was found that the output measurement for all 3 measurements were in
close agreement. Having this additional information from MPC is not critical, but it serves as an
additional layer of quality assurance checks.

ACR MR Image Analysis Instructions
The American College of Radiology (ACR) MRI phantom was scanned to evaluate the image
quality.36 The image quality parameters analyzed are listed in Table 11. These tests were
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selected and performed per the guidance of the ACR guidance document that assists facilities in
performing quality control and system performance testing.

Table 11 - ARC MR INSTRUMENT PARAMETERS
ACR MR Instrument Parameters
Geometry Accuracy
High-Contrast Spatial Resolution
Slice Thickness Accuracy
Slice Position Accuracy
Image Intensity Uniformity
Percent-Signal Ghosting
Low-Contrast Object
Detectability

For SRS cases, having high spatial resolution devoid of geometric distortions is
imperative especially due to the tight treatment margins. To evaluate distortions the geometric
accuracy is tested which involves measuring lengths on the images and comparing these values
to the known lengths of the phantom. Following the instructions of the ACR guidance
document,36 the window level (WL) was adjusted to better visualize the phantom. Then
measurements of the phantom in the in-plane and sagittal plane were measured to be ~190
mm and 148 mm, respectively. Figure 31 & Figure 32 display the length measurements.
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Figure 31 - INPLANE GEOMETRIC ACCURACY

Figure 32 - SAGITTAL END TO END LENGTH MEASUREMENT

The expected values of the inside diameter of the phantom and the end-to-end length of the
phantom was 190 mm and 148 mm, respectively. The measured values are well within the
action criteria as they are within 2 mm. The high-contrast spatial resolution test is performed
when the scanner’s contrast-to-noise is high where the ability of the scanner is tested to
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resolve small objects. In the ACR phantom there are 3 pairs of matrices that are squarish in
shape. Each row and column are evaluated by determining if one hole is distinguishable from
one another. Figure 33 represents the matrix of objects used for the high-contrast spatial
resolution test. This process is repeated for the remaining two arrays where all holes in relation
to the adjacent hole is evaluated on whether it is distinguishable from another. A 1 mm
resolution is required which can be satisfied if some of the holes for the vertical and horizontal
direction can be resolved in the middle array.

Figure 33 - HIGH CONTRAST SPATIAL RESOLUTION

The slice position accuracy test assesses if the slices are at specific locations. This test analyzes
the length differences between two bars (right and left). If the two bars differ by a length
greater than 5mm, there may be a few different scenarios causing this test to fail. For example,
a failure of this test may be due to the table positioning system. An example of the two bars is
displayed in Figure 34.
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Figure 34 - SLICE POSITION ACCURACY TEST

To test for slice thickness accuracy the length of two signal ramps in the phantom are
evaluated. The window level is adjusted to visualize ramps as seen in Figure 35.

Figure 35 - SLICE THICKNESS ACCURACY (SIGNAL RAMPS)
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Then, the mean ramp signal (HU) is measured and then the window level is lowered by half of
the signal measured. Then, the length of the two ramps is measured and recorded. These two
values are then used to calculate the slice thickness using Equation 5.

CDE;F )ℎE;HIFJJ = 0.2

L=∗MLNNL%

L=OMLNNL%

[5]

A large volume of water is analyzed in the phantom for uniformity of image intensity. This is
performed by lowering the window level until the phantom displays the color white. Next, the
lower level is raised until dark pixels develop, which displays the area of the lowest signal. This
is represented by Figure 36.

Figure 36 - IMAGE INTENSITY UNIFORMITY
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Then the level is raised further until a small section of white pixels remain, which
signifies the area with the highest signal. These two values are recorded and plugged into
Equation 6 to calculate the percent integral uniformity (PIU).
P : = 100 Q1 −

STUSV>LW
STUSO>LW

X

[6]

To measure the quantity of ghosting artifact in the phantom, the percent signal ghosting test is
used. 5 average signal measurements are taken. The first measurement is the HU measured
across the phantom, and the other 4 are measured in the right, left, top, and bottom directions
just outside of the phantom as seen in Figure 37.

Figure 37 - PERCENT SIGNAL GHOSTING

These recorded measurements are used to calculate the ghosting ratio using Equation 7.
ℎYJZEI[ +\ZEY = ]

L=OMN%V^,-NV TUSN
∗ S&?NL% _`
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]

[7]

The last test performed is the low-contrast object detectability test. The purpose of this test is
to discern objects of low contrast from other pixels. This test is performed by adjusting the WL
until the low contrast circles are visible (See Figure 38).

Figure 38 - LOW-CONTRAST OBJECT DETECTABILITY

Then, starting with the largest diameter circle, the number of circles visible in that spoke
are counted. A spoke is considered to be visible if all three are counted. Then, the next circles
with a slightly smaller diameter are counted. This process is repeated once all visible spokes are
counted.
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Future Equipment and Technology
HyperArc
HyperArc37 is an additional software package offered through Varian that streamlines clinical
workflow for SRS cases. This software simplifies the treatment planning and treatment delivery
process and provides additional tools to assess the quality of a treatment plan. As advertised on
Varian’s website, the dosimetrist has access to tools that optimize the dose and the treatment
delivery while receiving feedback on the plan quality. Additionally, the software will provide
suggestions on imaging way points, it provides a tool to visualize the treatment delivery
sequence, and it requires less therapist user input during treatment delivery. Acquisition of this
product will reduce the investment of resources (e.g. dosimetrist planning time, beam delivery
time, etc.), which in turn will allow resources to be redirected to other areas. This scenario is
particularly favorable when UVH is experiencing high patient volumes.

Independent MU verification algorithm
The 3-Source algorithm in IMSure algorithm provides a 2nd independent check on the dose and
MUs that were to be delivered to the patient. This algorithm was sufficient when providing
these checks for standard 3DCRT plans, IMRT plans, and for VMAT plans. However, with the
advent of small fields in SRS and SBRT and treating in heterogeneities, there have been
considerable discrepancies between the IMSure algorithm and the primary dose calculation
algorithm, Acuros. Therefore, the Radiation Oncology department is currently exploring
modern 3D algorithms that can better account for heterogeneities and small fields. Varian
Mobius 3D, Sun Nuclear DoseCheck and IBA SciMoCa are all being actively compared to serve
this purpose.38–40
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SRS MapCheck
Using film to verify dose planes for SRS plans is resource intensive which requires a physicist to
prepare the phantom with film, to find time available to use the treatment machine, and post
processing before a comparison can be made. This process is especially demanding in times
when there is a high workload of patients being treated during the day which will limit the
physicists’ opportunity to use the machine during normal working hours and when their time is
devoted to other tasks in the department. A tool that is capable of measuring SRS dose planes
and providing near instantaneous feedback would eliminate many of the challenges as
described above. One tool being capable of offering this kind of utility is the SRS Mapcheck.41
This device is composed of 1,013 diode detectors in an active area of 7.7 cm to 7.7 cm. This
device is capable of measuring multiple planes of dose and it is able to take the 3D dose DICOM
file from the treatment plan that is exported from the Eclipse TPS and import into the SRS
Mapcheck software. From there, it is able to make gamma analysis comparisons of the dose
being delivered to the dose calculated by the TPS. The UVH Radiation Oncology department is
expecting to purchase this equipment in 2020. It is expected that this equipment will replace
the film QA process and utilize less resources from the department.
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Conclusion
Utah Valley Hospital was charged with implementing a SRS program as an additional line of
service. The deliverable was a timely, validated SRS program. This required a significant
undertaking from the physics team, but also the dosimetrists, therapists, physicians, and
management. The process first began with each physicist brainstorming various items that
would need to be completed before implementing the program and conversing with various
staff members to receive their input. For example, one notable conversation was whether to
commission the cones in the department. Once the physics team had created a list of all the
items needed for the SRS program, it was set into motion. One of those items was the
evaluation of the patient specific QA to ensure that those tests were adequate. For example,
one item of concern was using the IC point dose measurement to compare the measurement to
the TPS value. Since SRS uses small fields it was a concern that the differences between the two
values may be considerable as the field sizes became smaller. Then there were efforts into
validating the beam delivery process and incorporating a patient specific QA process that was
representative of an E2E test. This invoked the use of the gafchromic film in previous
stereotactic body radiation therapy treatments to test the workflow of this QA process and the
feasibility of it. Next an independent E2E validation test was performed with the SRS head
phantom (HAMLET) that was provided by IROC. While these projects were being conducted on
the beam delivery, there were also efforts put forth in researching various metrics to include
when evaluating a SRS plan. Finally, there were meetings between various individuals to set up
processes related to the program. For example, a physicist met with MR staff members to
discuss which scan protocols would provide the most valuable MR images and receiving scans
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of the ARC MRI phantom to evaluate the image quality. An additional example is the radiation
oncologists and physicists meeting with the neurosurgeons to involve their clinical expertise
with these SRS cases. After validating the SRS program and treating the first couple of cases,
additional efforts were made to improve upon the clinical workflow and processes. For
example, it is expected that the size of Provo, Utah, where UVH is located, will continue to grow
in population and thus the workload for department staff will increase. To account for the
growing population, additional purchases have been made on technologic upgrades. For
example, acquisition of HyperArc and SRS Mapcheck is expected to decrease the time required
to plan, QA the plan, and to treat the patient. Lastly, while this document displays the
significance of various steps, it is important to recognize that implementing a SRS program
should be viewed as a dynamic process. The radiation therapy field is constantly changing, and
new technology is becoming available which simplifies many of the mundane and/or
undesirable tasks. For example, only recently has frameless SRS treatments performed on
LINACs become easily achieved on a general use LINAC. A large part of this change was due to
the introduction of surface tracking that replaced the need for frame-based SRS programs. Also,
within the UVH Radiation Oncology department, attempts have been made that hold true to
this dynamic philosophy. For example, one of the physicists proposed adding a Styrofoam
mannequin face mounted on a slab as an add on to the stereotactic dose verification phantom.
The idea was to integrate the VisionRT tracking system into the IC measurement QA to measure
the absolute dose of a point while characterizing the VisionRT shift readouts throughout the QA
process. Although this idea was tabled, it is true to the virtue of recognizing the fluidity of an
ever-changing field.
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Appendix A: Film QA
Film fragment calibration technique:
Gafchromic RTQA2 Film & Espon 10000XL Flat Bed Scanner are used
1. A sheet of Gafchromic RTQA2 film is taken and cut up into 12 squares each
measuring 6.35 cm by 6.35 cm
2. Set a 5 cm water equivalent block on the treatment couch and set the SSD readout
on the block to 100 cm
3. Create a 10x10 ;< field, center the water block to the light field cross hair, and
place the film square on the water block and center it to the light field cross hair
4. Place a 5 cm water equivalent block on top of the film and water block. Each film
piece is irradiated to a different dose to reconstruct the sensiometric curve. See
Table 12 for a representative list of dose values

Table 12 - SENSIOMETRIC CURVE DATA FOR 10 FFF
10FFF
D5TMR
0.952
Film at 100SAD/Isocenter
Dose
(cGy)
MU
0
0
25
26
50
53
75
79
100
105
150
158
200
210
300
315
400
420
500
525
600
630
700
735

5. Irradiate the film square using the appropriate MU to the specified dose (as seen in
Table 12)
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6. Once irradiated, place a sticky note onto the back of each film piece with the known
MU and dose to distinguish it from the other irradiated film pieces
7. Repeat the steps above to irradiate additional pieces of film to a different dose
8. Scan each film piece following the writeup titled, “Film Scanning”
9. Open ImageJ and drag one of the film scans into the software
10. Select “Image”, “Color”, “Split Channels” and close all windows except the red
channel
11. Left click on the image and drag a region of interest box over the area to be
measured
12. Press “Control m” to record the measured optical density
13. Record this value as it relates the OD to dose. Repeat steps 11-12 for all film
fragments
Gafchromic RTQA2 film irradiation for patient specific plans
1. Create verification plan using Pt. ID sp11/04/2016. Image set: Film-V-512-0.8
a. This is the blue phantom in film configuration, vertical orientation, 512 axial
matrix, 0.8mm slices
2. Verify the dose distributions of interest fall intersect the position of the film on the
CT. If the dose distributions are not intersecting the film, the isocenter may need to
be shifted.
3. Approve the plan (planning approved) and schedule it for delivery on the TrueBeam
4. While wearing gloves, cut out a 6.35 cm by 6.35 cm film square and place it in onto
the film slab from the blue cube phantom (2 corners of the film may be clipped to
ensure a good fit)
5. Place the film slab with the other film slabs onto the two anchors embedded in the
bottom component of the blue cube. Lastly place the remaining blue cube
component and tighten with provided screws
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6. Align the blue cube phantom to the lasers in the treatment vault and use the light
field crosshair to make any final adjustments

7. Pull up the patient specific film QA plan and acquire a cone beam CT to further align
the phantom and irradiate the phantom with the embedded film
8. Irradiate the phantom with the embedded film using all arcs

Film Scanning
1. All films scanned should be placed near the center of the scanner to avoid lateral
scan effects and should be straightened out (void of rotations). The ROI tool can
assist in identifying significant rotations.
2. Once the film is placed onto the scanner, the following scan parameters listed below
are used (See Figure 39)

Figure 39 - FILM SCAN PARAMETERS

3. Once all image correction options are turned off, the film can be scanned
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4. All scanned films are saved in the TIFF file format

Comparison of an axial TPS dose plane compared to an axial dose on film
1.

Open the ImageJ software

2.

Drag in the scanned patient specific QA film image

3.

Select “Image”, “Color”, “Split Channels”. Close green and blue channel
windows, leaving only the red channel

4.

Select “Image” and “Crop” to only include the region of interest on the film.
Ensure the film dimensions are equal (e.g. 512 x 512). Record the pixel size and
length in inches for the rows and columns (This information is used later).
Calculate the resolution by multiplying the length [inches] by 25.4 and divide by
the pixels (e.g. 2.5 inch * 25.4 mm/inch / 512 = 0.124 mm/pixel)

5.

Pull up the sensiometric curve values (dose and OD) generated from the “Film
fragment calibration technique” In Image J, select “Analyze” then “Calibrate”.
Function: 3rd Degree Polynomial, Unit: cGy, type in dose values for each film on
Right side. Select “Yes” Global Calibration. Save, OK

6.

Select “process” then “filters” and “median” and type in the value of 3 to filter
out irregularities in the film

7.

Using the following header (Figure 40) below, paste to matrix of dose values just
under the [Data] row.
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[General]
FileFormat=Generic Dosimetry Exchange Format
Version=1.0
Creator=Review
CreatorVersion=7.1.35
[Geometry]
Dimensions=2
Axis1=X
Size1=[*NEED TO ENTER FIRST PIXEL SIZE* e.g. 512]
Res1= [*NEED TO ENTER RESOLUTION IN MM* e.g. 0.124]
Offset1=0
Unit1=mm
Separator1=\t
Axis2=Y
Size2= [*NEED TO ENTER SECOND PIXEL SIZE* e.g. 512]
Res2= [*NEED TO ENTER RESOLUTION IN MM* e.g. 0.124]
Offset2=0
Unit2=mm
Separator2=\n
[Interpretation]
Type=Acquired Portal
DataType=%f
Unit=CU
Location=Imager
Medium=Ion Chamber
[Patient]
PatientId1= 1000000
PatientId2=
LastName= John
FirstName= Doe
[Field]
PlanId= 1111111111
FieldId= 2
ExternalBeamId=Toestel 5
BeamType=Photon
Energy=6
SAD=100
Scale=IEC1217
GantryAngle=0
CollRtn=0
CollX1=-2
CollX2=2
CollY1=-2
CollY2=2
[PortalDose]
SID=100
Date=01/20/2020, 13:25:33
[Data]
[*ENTER ALL DATA VALUES BELOW*]

Figure 40 - PORTAL DOSIMETRY TEXT DATA FILE
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8.

In (Figure 40) update the size and resolution rows using the values calculated
and recorded from step 7

9.

More information can be updated for accuracy, but it’s not required to
successfully import into the Portal Dosimetry workspace

10.

Save the text file in the .dxf format with the following name “Film QA Data”

11.

Next the TPS axial plane of dose must be exported and formatted for Portal
Dosimetry import. Open the patient film QA plan created in the “Gafchromic
RTQA2 film irradiation for patient specific plans” writeup

12.

Right click the dose and export the dose plane corresponding to the center of the
film. Make sure the axial plane window is selected.

13.

The following is selected when exporting the axial dose plane to a local folder:
Absolute dose; Planar plan dose; Size-6.35 cm, Pixels-512

14.

Import the file created in step (13) (Disregard message saying image is
incompatible with calibration)

15.

Select “Image” and “Show info” (See Below)

16.

Record the last line This last line is the conversion of image values to Gy. To
convert to cGy multiply by 100.

17.

Select “Process” then “Math” then “Multiply” and enter value from above to
convert to cGy.

18.

Select “File” then “Save As” and “Text Image”

19.

Repeat steps 7-9 above for this file

20.

Save the text file in the .dxf format with the following name “TPS Data”
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21.

Import both .dxf files (“TPS DATA” and “Film QA Data”) into Portal Dosimetry to
perform a Gamma Analysis comparison.
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Appendix B: Stereotactic Radiosurgery Head Phantom Irradiation Results
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Curriculum Vitae

E-mail: rsharp156@gmail.com

Therapeutic Medical Physicist
2 years of clinical experience

2012 - Present Education:
2018 - 2020 Doctor of Medical Physics (DMP)
University of Nevada, Las Vegas: CAMPEP Accredited Graduate Program
• Residency experience at: Intermountain Healthcare (Provo, Utah & American Fork, Utah)
Northern Nevada Radiation Oncology (Reno, Nevada)

2016 - 2018 M.S. of Health Physics: Concentration in Medical Physics
University of Nevada, Las Vegas: CAMPEP Accredited Graduate Program
• Thesis performed under supervision of Benjamin Smith & Matthew Schmidt with Varian Medical
Systems: “Electron Monte Carlo Dose Calculation Model Dependency on Optional Applicator
Specific 1D Profiles”

2012 - 2016 B.S. of Nuclear Engineering & minor in Mathematics
University of New Mexico
• Senior Design Project: “Low Enriched High Flux Moly-99 Medical Isotope Production Reactor”

2018 – Present Clinical Experience:
Linac EBRT: Varian TrueBeam equipped with FF & FFF photons, electrons, integrated with a 6
DOF couch, kV/MV imaging, & VisionRT
Clinac iX equipped with FF photons, electrons, integrated with kV/MV imaging, & Calypso
•
•
•
•

Performing daily, monthly, & annual QA (TG51, TG142, TG56, & TG40)
Running pretreatment QA using a variety of QA tools (see attached equipment list)
Characterizing VisonRT's thermal drift
Performing monthly EPID & CT QA

Treatment Planning System: Eclipse
EBRT Planning:
•

Practice plans: (20 cases planned)
o 3DCRT, IMRT, VMAT & SBRT planning (breast, lung, prostate, & H&N)
o SRS planning

RapidPlan Implementation:
•
•

Built RapidPlan prostate model for clinical use
Validated efficacy of model by comparing to clinical plans
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Treatment Planning System QA:
•
•

Following TG53 and MPPG 5.A recommendations, a series of tests plans were created &
compared against measured scans & IMSure
Test plans used as benchmarks following the Eclipse/Aria upgrade to version 15

Brachytherapy: HDR & LDR:
HDR: BrachyVision & GammaMedPlus iX
•

•
•

Clinical Planning Experience: (50 cases planned)
o Breast (SAVI, interstitial, & AccuBoost)
o GYN (Cylinder, T&R, T&O, & interstitial)
o Custom surface applicators
o Prostate interstitial
Responsible for HDR source exchange and daily QA
Performed 2nd independent checks on HDR plans using RadCalc

LDR: IsoAid Stranded Pd-103 seeds:
•
•

Volume study, ordering, receiving, shipping, and handling Pd-103 seeds
Assist Physician with seed implant in OR

EyePlaque: IsoAid I-125 seeds:
•
•
•

Observation of planning of plaque in BrachyVision and Plaque Simulator
Assaying source strength & loading seeds into plaque
Observing placement & removal of eye plaque

Xofigo Injections:
•
•

Receiving, surveying, & handling radioactive material
Assaying and preparing radionuclide(s) for patient injection

Film Dosimetry:
•
•
•

Created excel spreadsheet for reference film calibration using Gafchromic film
Generated a fragment calibration curve in ImageJ
Performed a feasibility test of calibrating plan specific film and comparing it to an axial dose
plane in Portal Dosimetry

2012 – 2018 Graduate & Undergraduate Experience:
2017 – 2018 Volunteer at Comprehensive Cancer Centers of Nevada:
•
•
•

Performed TG51 under the direct supervision of an ABR certified physicist
Assisted with monthly & annual TG142
Observed HDR source exchange
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2017 – 2018 Commissioning (Research based) at Varian Medical Systems:
•
•
•

Acquired PDDs, profiles, and output factors required for commissioning electron Monte Carlo
(eMC)
Configured eMC algorithm and benchmarked against TrueBeam Representative Beam Data
Configured two eMC algorithms (characterizing impact of including optional profiles in eMC)

2017 – 2018 Clinical Training Courses taken at Varian Medical Systems:
•
•
•
•
•

EC101 Eclipse Basic Operations
EC201 Eclipse Commissioning I: Administration and Algorithms
EC204 Beam Data Scanning
EC301 Eclipse Scripting API Basics
ECB101 3D BrachyVision

2016 – 2018 Graduate Teaching Assistant for Radiation Biology at UNLV:
•

Lecturing, preparing presentations, & grading coursework

2014 – 2016 Radiation Safety Assistant at UNM Health Sciences Center:
•
•
•
•
•
•

Surveying of research laboratories
Performed gamma spectroscopy on unlabeled legacy sources to identify and quantify unknown
radioactive material
Assist with preparation of radioactive waste for outgoing shipment
Receiving, surveying, & delivering radioactive materials
Surveying for possible radiation contamination in I131, Zevalin, Xofigo, and SirSphere cases
Responsible for conducting daily checks on radiation detectors

Achievements and Memberships:
•
•
•

•

Passed ABR Part 1: General and Clinical sections
In accordance with 49 CRF 172.704, completed training for receiving and shipping
radiopharmaceuticals
Student member of the American Nuclear Society (ANS), American Association of Physicists in
Medicine (AAPM), American Brachy Society (ABS), Radiosurgery Society (RSS), & Health Physics
Society (HPS)
Best in Presentation in Isotopes & Radiation ANS Student Conference 2016
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